The global market for Lung Cancer Vaccine is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Lung Cancer Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Lung Cancer Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Lung Cancer Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Lung Cancer Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Lung Cancer Vaccine players cover GlaxoSmithKline, Oncothyreon Incorporation, Eli Lily, ImClone Systems and Boehringer Ingelheim, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Lung Cancer Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Lung Cancer Vaccine market, with both quantitative and qualitative data, to help readers understand how the Lung Cancer Vaccine market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Lung Cancer Vaccine market and forecasts the market size by Type (Subunit Vaccines, Live Attenuated Vaccines and Conjugate Vaccines), by Application (Man and Woman.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Subunit Vaccines
Live Attenuated Vaccines
Conjugate Vaccines
Inactivated Vaccines
Recombinant Vector Vaccines
Segmentation by application
Man
Woman
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
GlaxoSmithKline
Oncothyreon Incorporation
Eli Lily
ImClone Systems
Boehringer Ingelheim
Merck
Ono Pharmaceutical
CureVac
Chapter Introduction
Chapter 1: Scope of Lung Cancer Vaccine, Research Methodology, etc.
Chapter 2: Executive Summary, global Lung Cancer Vaccine market size (sales and revenue) and CAGR, Lung Cancer Vaccine market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Lung Cancer Vaccine sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Lung Cancer Vaccine sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Lung Cancer Vaccine market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including GlaxoSmithKline, Oncothyreon Incorporation, Eli Lily, ImClone Systems, Boehringer Ingelheim, Merck, Ono Pharmaceutical and CureVac, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Lung Cancer Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Lung Cancer Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Lung Cancer Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Lung Cancer Vaccine Segment by Type
2.2.1 Subunit Vaccines
2.2.2 Live Attenuated Vaccines
2.2.3 Conjugate Vaccines
2.2.4 Inactivated Vaccines
2.2.5 Recombinant Vector Vaccines
2.3 Lung Cancer Vaccine Sales by Type
2.3.1 Global Lung Cancer Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Lung Cancer Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Lung Cancer Vaccine Sale Price by Type (2017-2022)
2.4 Lung Cancer Vaccine Segment by Application
2.4.1 Man
2.4.2 Woman
2.5 Lung Cancer Vaccine Sales by Application
2.5.1 Global Lung Cancer Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Lung Cancer Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Lung Cancer Vaccine Sale Price by Application (2017-2022)
3 Global Lung Cancer Vaccine by Company
3.1 Global Lung Cancer Vaccine Breakdown Data by Company
3.1.1 Global Lung Cancer Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Lung Cancer Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Lung Cancer Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Lung Cancer Vaccine Revenue by Company (2020-2022)
3.2.2 Global Lung Cancer Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Lung Cancer Vaccine Sale Price by Company
3.4 Key Manufacturers Lung Cancer Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lung Cancer Vaccine Product Location Distribution
3.4.2 Players Lung Cancer Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Lung Cancer Vaccine by Geographic Region
4.1 World Historic Lung Cancer Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Lung Cancer Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Lung Cancer Vaccine Annual Revenue by Geographic Region
4.2 World Historic Lung Cancer Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Lung Cancer Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Lung Cancer Vaccine Annual Revenue by Country/Region
4.3 Americas Lung Cancer Vaccine Sales Growth
4.4 APAC Lung Cancer Vaccine Sales Growth
4.5 Europe Lung Cancer Vaccine Sales Growth
4.6 Middle East & Africa Lung Cancer Vaccine Sales Growth
5 Americas
5.1 Americas Lung Cancer Vaccine Sales by Country
5.1.1 Americas Lung Cancer Vaccine Sales by Country (2017-2022)
5.1.2 Americas Lung Cancer Vaccine Revenue by Country (2017-2022)
5.2 Americas Lung Cancer Vaccine Sales by Type
5.3 Americas Lung Cancer Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lung Cancer Vaccine Sales by Region
6.1.1 APAC Lung Cancer Vaccine Sales by Region (2017-2022)
6.1.2 APAC Lung Cancer Vaccine Revenue by Region (2017-2022)
6.2 APAC Lung Cancer Vaccine Sales by Type
6.3 APAC Lung Cancer Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Lung Cancer Vaccine by Country
7.1.1 Europe Lung Cancer Vaccine Sales by Country (2017-2022)
7.1.2 Europe Lung Cancer Vaccine Revenue by Country (2017-2022)
7.2 Europe Lung Cancer Vaccine Sales by Type
7.3 Europe Lung Cancer Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Lung Cancer Vaccine by Country
8.1.1 Middle East & Africa Lung Cancer Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Lung Cancer Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Lung Cancer Vaccine Sales by Type
8.3 Middle East & Africa Lung Cancer Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lung Cancer Vaccine
10.3 Manufacturing Process Analysis of Lung Cancer Vaccine
10.4 Industry Chain Structure of Lung Cancer Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lung Cancer Vaccine Distributors
11.3 Lung Cancer Vaccine Customer
12 World Forecast Review for Lung Cancer Vaccine by Geographic Region
12.1 Global Lung Cancer Vaccine Market Size Forecast by Region
12.1.1 Global Lung Cancer Vaccine Forecast by Region (2023-2028)
12.1.2 Global Lung Cancer Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Lung Cancer Vaccine Forecast by Type
12.7 Global Lung Cancer Vaccine Forecast by Application
13 Key Players Analysis
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Lung Cancer Vaccine Product Offered
13.1.3 GlaxoSmithKline Lung Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 Oncothyreon Incorporation
13.2.1 Oncothyreon Incorporation Company Information
13.2.2 Oncothyreon Incorporation Lung Cancer Vaccine Product Offered
13.2.3 Oncothyreon Incorporation Lung Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Oncothyreon Incorporation Main Business Overview
13.2.5 Oncothyreon Incorporation Latest Developments
13.3 Eli Lily
13.3.1 Eli Lily Company Information
13.3.2 Eli Lily Lung Cancer Vaccine Product Offered
13.3.3 Eli Lily Lung Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Eli Lily Main Business Overview
13.3.5 Eli Lily Latest Developments
13.4 ImClone Systems
13.4.1 ImClone Systems Company Information
13.4.2 ImClone Systems Lung Cancer Vaccine Product Offered
13.4.3 ImClone Systems Lung Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 ImClone Systems Main Business Overview
13.4.5 ImClone Systems Latest Developments
13.5 Boehringer Ingelheim
13.5.1 Boehringer Ingelheim Company Information
13.5.2 Boehringer Ingelheim Lung Cancer Vaccine Product Offered
13.5.3 Boehringer Ingelheim Lung Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Boehringer Ingelheim Main Business Overview
13.5.5 Boehringer Ingelheim Latest Developments
13.6 Merck
13.6.1 Merck Company Information
13.6.2 Merck Lung Cancer Vaccine Product Offered
13.6.3 Merck Lung Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Merck Main Business Overview
13.6.5 Merck Latest Developments
13.7 Ono Pharmaceutical
13.7.1 Ono Pharmaceutical Company Information
13.7.2 Ono Pharmaceutical Lung Cancer Vaccine Product Offered
13.7.3 Ono Pharmaceutical Lung Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Ono Pharmaceutical Main Business Overview
13.7.5 Ono Pharmaceutical Latest Developments
13.8 CureVac
13.8.1 CureVac Company Information
13.8.2 CureVac Lung Cancer Vaccine Product Offered
13.8.3 CureVac Lung Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 CureVac Main Business Overview
13.8.5 CureVac Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Lung Cancer Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Lung Cancer Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Subunit Vaccines
Table 4. Major Players of Live Attenuated Vaccines
Table 5. Major Players of Conjugate Vaccines
Table 6. Major Players of Inactivated Vaccines
Table 7. Major Players of Recombinant Vector Vaccines
Table 8. Global Lung Cancer Vaccine Sales by Type (2017-2022) & (K Units)
Table 9. Global Lung Cancer Vaccine Sales Market Share by Type (2017-2022)
Table 10. Global Lung Cancer Vaccine Revenue by Type (2017-2022) & ($ million)
Table 11. Global Lung Cancer Vaccine Revenue Market Share by Type (2017-2022)
Table 12. Global Lung Cancer Vaccine Sale Price by Type (2017-2022) & (US$/Unit)
Table 13. Global Lung Cancer Vaccine Sales by Application (2017-2022) & (K Units)
Table 14. Global Lung Cancer Vaccine Sales Market Share by Application (2017-2022)
Table 15. Global Lung Cancer Vaccine Revenue by Application (2017-2022)
Table 16. Global Lung Cancer Vaccine Revenue Market Share by Application (2017-2022)
Table 17. Global Lung Cancer Vaccine Sale Price by Application (2017-2022) & (US$/Unit)
Table 18. Global Lung Cancer Vaccine Sales by Company (2020-2022) & (K Units)
Table 19. Global Lung Cancer Vaccine Sales Market Share by Company (2020-2022)
Table 20. Global Lung Cancer Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Lung Cancer Vaccine Revenue Market Share by Company (2020-2022)
Table 22. Global Lung Cancer Vaccine Sale Price by Company (2020-2022) & (US$/Unit)
Table 23. Key Manufacturers Lung Cancer Vaccine Producing Area Distribution and Sales Area
Table 24. Players Lung Cancer Vaccine Products Offered
Table 25. Lung Cancer Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Lung Cancer Vaccine Sales by Geographic Region (2017-2022) & (K Units)
Table 29. Global Lung Cancer Vaccine Sales Market Share Geographic Region (2017-2022)
Table 30. Global Lung Cancer Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Lung Cancer Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Lung Cancer Vaccine Sales by Country/Region (2017-2022) & (K Units)
Table 33. Global Lung Cancer Vaccine Sales Market Share by Country/Region (2017-2022)
Table 34. Global Lung Cancer Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Lung Cancer Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Lung Cancer Vaccine Sales by Country (2017-2022) & (K Units)
Table 37. Americas Lung Cancer Vaccine Sales Market Share by Country (2017-2022)
Table 38. Americas Lung Cancer Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Lung Cancer Vaccine Revenue Market Share by Country (2017-2022)
Table 40. Americas Lung Cancer Vaccine Sales by Type (2017-2022) & (K Units)
Table 41. Americas Lung Cancer Vaccine Sales Market Share by Type (2017-2022)
Table 42. Americas Lung Cancer Vaccine Sales by Application (2017-2022) & (K Units)
Table 43. Americas Lung Cancer Vaccine Sales Market Share by Application (2017-2022)
Table 44. APAC Lung Cancer Vaccine Sales by Region (2017-2022) & (K Units)
Table 45. APAC Lung Cancer Vaccine Sales Market Share by Region (2017-2022)
Table 46. APAC Lung Cancer Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Lung Cancer Vaccine Revenue Market Share by Region (2017-2022)
Table 48. APAC Lung Cancer Vaccine Sales by Type (2017-2022) & (K Units)
Table 49. APAC Lung Cancer Vaccine Sales Market Share by Type (2017-2022)
Table 50. APAC Lung Cancer Vaccine Sales by Application (2017-2022) & (K Units)
Table 51. APAC Lung Cancer Vaccine Sales Market Share by Application (2017-2022)
Table 52. Europe Lung Cancer Vaccine Sales by Country (2017-2022) & (K Units)
Table 53. Europe Lung Cancer Vaccine Sales Market Share by Country (2017-2022)
Table 54. Europe Lung Cancer Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Lung Cancer Vaccine Revenue Market Share by Country (2017-2022)
Table 56. Europe Lung Cancer Vaccine Sales by Type (2017-2022) & (K Units)
Table 57. Europe Lung Cancer Vaccine Sales Market Share by Type (2017-2022)
Table 58. Europe Lung Cancer Vaccine Sales by Application (2017-2022) & (K Units)
Table 59. Europe Lung Cancer Vaccine Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Lung Cancer Vaccine Sales by Country (2017-2022) & (K Units)
Table 61. Middle East & Africa Lung Cancer Vaccine Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Lung Cancer Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Lung Cancer Vaccine Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Lung Cancer Vaccine Sales by Type (2017-2022) & (K Units)
Table 65. Middle East & Africa Lung Cancer Vaccine Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Lung Cancer Vaccine Sales by Application (2017-2022) & (K Units)
Table 67. Middle East & Africa Lung Cancer Vaccine Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Lung Cancer Vaccine
Table 69. Key Market Challenges & Risks of Lung Cancer Vaccine
Table 70. Key Industry Trends of Lung Cancer Vaccine
Table 71. Lung Cancer Vaccine Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Lung Cancer Vaccine Distributors List
Table 74. Lung Cancer Vaccine Customer List
Table 75. Global Lung Cancer Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 76. Global Lung Cancer Vaccine Sales Market Forecast by Region
Table 77. Global Lung Cancer Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Lung Cancer Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Lung Cancer Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 80. Americas Lung Cancer Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Lung Cancer Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 82. APAC Lung Cancer Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Lung Cancer Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Europe Lung Cancer Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Lung Cancer Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 86. Middle East & Africa Lung Cancer Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Lung Cancer Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 88. Global Lung Cancer Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Lung Cancer Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Lung Cancer Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Lung Cancer Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 92. Global Lung Cancer Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Lung Cancer Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Lung Cancer Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 95. GlaxoSmithKline Basic Information, Lung Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 96. GlaxoSmithKline Lung Cancer Vaccine Product Offered
Table 97. GlaxoSmithKline Lung Cancer Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 98. GlaxoSmithKline Main Business
Table 99. GlaxoSmithKline Latest Developments
Table 100. Oncothyreon Incorporation Basic Information, Lung Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 101. Oncothyreon Incorporation Lung Cancer Vaccine Product Offered
Table 102. Oncothyreon Incorporation Lung Cancer Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 103. Oncothyreon Incorporation Main Business
Table 104. Oncothyreon Incorporation Latest Developments
Table 105. Eli Lily Basic Information, Lung Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 106. Eli Lily Lung Cancer Vaccine Product Offered
Table 107. Eli Lily Lung Cancer Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 108. Eli Lily Main Business
Table 109. Eli Lily Latest Developments
Table 110. ImClone Systems Basic Information, Lung Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 111. ImClone Systems Lung Cancer Vaccine Product Offered
Table 112. ImClone Systems Lung Cancer Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 113. ImClone Systems Main Business
Table 114. ImClone Systems Latest Developments
Table 115. Boehringer Ingelheim Basic Information, Lung Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 116. Boehringer Ingelheim Lung Cancer Vaccine Product Offered
Table 117. Boehringer Ingelheim Lung Cancer Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 118. Boehringer Ingelheim Main Business
Table 119. Boehringer Ingelheim Latest Developments
Table 120. Merck Basic Information, Lung Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 121. Merck Lung Cancer Vaccine Product Offered
Table 122. Merck Lung Cancer Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 123. Merck Main Business
Table 124. Merck Latest Developments
Table 125. Ono Pharmaceutical Basic Information, Lung Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 126. Ono Pharmaceutical Lung Cancer Vaccine Product Offered
Table 127. Ono Pharmaceutical Lung Cancer Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 128. Ono Pharmaceutical Main Business
Table 129. Ono Pharmaceutical Latest Developments
Table 130. CureVac Basic Information, Lung Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 131. CureVac Lung Cancer Vaccine Product Offered
Table 132. CureVac Lung Cancer Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 133. CureVac Main Business
Table 134. CureVac Latest Developments
List of Figures
Figure 1. Picture of Lung Cancer Vaccine
Figure 2. Lung Cancer Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Lung Cancer Vaccine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Lung Cancer Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Lung Cancer Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Subunit Vaccines
Figure 10. Product Picture of Live Attenuated Vaccines
Figure 11. Product Picture of Conjugate Vaccines
Figure 12. Product Picture of Inactivated Vaccines
Figure 13. Product Picture of Recombinant Vector Vaccines
Figure 14. Global Lung Cancer Vaccine Sales Market Share by Type in 2021
Figure 15. Global Lung Cancer Vaccine Revenue Market Share by Type (2017-2022)
Figure 16. Lung Cancer Vaccine Consumed in Man
Figure 17. Global Lung Cancer Vaccine Market: Man (2017-2022) & (K Units)
Figure 18. Lung Cancer Vaccine Consumed in Woman
Figure 19. Global Lung Cancer Vaccine Market: Woman (2017-2022) & (K Units)
Figure 20. Global Lung Cancer Vaccine Sales Market Share by Application (2017-2022)
Figure 21. Global Lung Cancer Vaccine Revenue Market Share by Application in 2021
Figure 22. Lung Cancer Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Lung Cancer Vaccine Revenue Market Share by Company in 2021
Figure 24. Global Lung Cancer Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Lung Cancer Vaccine Revenue Market Share by Geographic Region in 2021
Figure 26. Global Lung Cancer Vaccine Sales Market Share by Region (2017-2022)
Figure 27. Global Lung Cancer Vaccine Revenue Market Share by Country/Region in 2021
Figure 28. Americas Lung Cancer Vaccine Sales 2017-2022 (K Units)
Figure 29. Americas Lung Cancer Vaccine Revenue 2017-2022 ($ Millions)
Figure 30. APAC Lung Cancer Vaccine Sales 2017-2022 (K Units)
Figure 31. APAC Lung Cancer Vaccine Revenue 2017-2022 ($ Millions)
Figure 32. Europe Lung Cancer Vaccine Sales 2017-2022 (K Units)
Figure 33. Europe Lung Cancer Vaccine Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Lung Cancer Vaccine Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Lung Cancer Vaccine Revenue 2017-2022 ($ Millions)
Figure 36. Americas Lung Cancer Vaccine Sales Market Share by Country in 2021
Figure 37. Americas Lung Cancer Vaccine Revenue Market Share by Country in 2021
Figure 38. United States Lung Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Lung Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Lung Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Lung Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Lung Cancer Vaccine Sales Market Share by Region in 2021
Figure 43. APAC Lung Cancer Vaccine Revenue Market Share by Regions in 2021
Figure 44. China Lung Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Lung Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Lung Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Lung Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Lung Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Lung Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Lung Cancer Vaccine Sales Market Share by Country in 2021
Figure 51. Europe Lung Cancer Vaccine Revenue Market Share by Country in 2021
Figure 52. Germany Lung Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Lung Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Lung Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Lung Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Lung Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Lung Cancer Vaccine Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Lung Cancer Vaccine Revenue Market Share by Country in 2021
Figure 59. Egypt Lung Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Lung Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Lung Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Lung Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Lung Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Lung Cancer Vaccine in 2021
Figure 65. Manufacturing Process Analysis of Lung Cancer Vaccine
Figure 66. Industry Chain Structure of Lung Cancer Vaccine
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)